November 16, 2016 - By Winifred Garcia · 0 Comments
Nov 16 is a negative day so far for First Trust SSI Strat Convert Secs ETF (NASDAQ:FCVT) as the ETF is active during the day after losing 0.79% to hit $25.26 per share. The exchange traded fund has 7.64M net assets and 0.77% volatility this month.
Over the course of the day 1,137 shares traded hands, as compared to an average volume of 9,020 over the last 30 days for First Trust SSI Strat Convert Secs ETF (NASDAQ:FCVT).
The ETF is -8.17% of its 52-Week High and 15.09% of its low, and is currently having ATR of 0.23. This year’s performance is 4.40% while this quarter’s performance is -2.68%.
The ETF’s YTD performance is 4.81%, the 1 year is NaN% and the 3 year is NaN%.
The ETF’s average P/E ratio is 8.97, the price to book is 1.81, the price to sales is 1.79 and the price to cashflow is 4.31. It was started on 11/04/2015. The fund’s top holdings are: Wells Fargo & Co San Francisco Ca Pfd for 3.25% of assets, Allergan Plc Convertible Preferred for 2.74%, Bk Amer Pfd for 2.55%, Priceline Grp Cv 0.35% for 2.49%, Hologic Cv for 2.37%, Nvidia Cv 1% for 2.14%, Intel Cv 3.25% for 2.06%, Dish Net 144A Cv 3.375% for 1.94%, Citrix Sys Cv 0.5% for 1.75%, Microchip Tech Cv 1.625% for 1.72%. The ETF sector weights are: Consumer Defensive 24.54%, Healthcare 9.28%, Utilities 56.23%, Energy 6.43%, Industrials 3.52%. The ETF currently as yield.
More recent First Trust SSI Strategic Convertible Securities ETF (NASDAQ:FCVT) news were published by: Businesswire.com which released: “First Trust to Launch the First Trust SSI Strategic Convertible Securities ETF” on November 02, 2015. Also Seekingalpha.com published the news titled: “ETF Update: An Abundance Of Currency Hedged ETFs” on November 14, 2015. Seekingalpha.com‘s news article titled: “ETF Deathwatch For June 2016: Currency-Hedged Zombies” with publication date: June 20, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Winifred Garcia